Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...

Panelists discuss how new dual-targeting agents and TKIs are redefining treatment approaches in EGFR-positive NSCLC.

Arkansas House Bill 1150 aims to protect independent pharmacies but may limit patient access and conflict with federal laws.

The study showed that hair loss disorders generally lead to impaired QOL, with psychological well-being being the most affected domain. The mean (SD) DLQI score for all participants was 7.86 (6.59), ...

Panelists discuss how CNS-active EGFR TKIs are improving intracranial outcomes and influencing treatment selection in NSCLC.

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

Increasing respiratory syncytial virus (RSV) vaccination among older adults could prevent up to 1600 deaths and 20,000 ...

ACA marketplace premiums are projected to rise by 26% in 2026, with potential further increases if premium tax credits expire ...

Phung explained that prior response often guides selection: Patients who respond poorly to frontline therapy may move to CAR ...

Equitable access to genomic testing for NSCLC patients is vital for advanced therapy access, with strategies including ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...